PAK
Signaling Pathway Map
Research Area
- Inhibitory Selectivity
- Solubility
| Catalog No. | Product Name | Solubility(25°C) | ||
|---|---|---|---|---|
| Water | DMSO | Alcohol | ||
| S7093 | IPA-3 | <1 mg/mL | 70 mg/mL | 7 mg/mL |
| S7094 | PF-3758309 | <1 mg/mL | 98 mg/mL | 98 mg/mL |
| S8444 | KPT-9274 | <1 mg/mL | 100 mg/mL | 100 mg/mL |
| S7271 | FRAX597 | <1 mg/mL | 14 mg/mL | 1 mg/mL |
| S7807 | FRAX486 | <1 mg/mL | 22 mg/mL | <1 mg/mL |
| S7989 | FRAX1036 | <1 mg/mL | <1 mg/mL | 20 mg/mL |
PAK Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S7093 |
IPA-3IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6). |
(e) Immunoblot analysis of p-ERM, p-Pak1 and Pak1 in Ishikawa cells treated with various doses of Pak1 inhibitor IPA-3 for 24 h. Actin serves as a loading control
|
|
| S7094 |
PF-3758309PF-03758309 is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4 with IC50 of 1.3 nM. |
(C) MEF lysates treated with 10 μM PF-3758309 and DMSO as control were loaded in a PhosTag gel. Phospho- and dephospho-proteins (PAK6 and 14-3-3γ) were visualized using anti-PAK6 or anti-pSer560 antibody and anti-14-3-3γ or anti-pSer58. Protein loading was controlled by western blot using anti-PAK6 and anti-14-3-3γ antibodies.
|
|
| S8444New |
KPT-9274KPT-9274 is an orally bioavailable small molecule that is a non-competitive dual inhibitor of PAK4 and NAMPT. It shows an IC50 of ~120 nM for NAMPT in a cell-free enzymatic assay. |
||
| S7271 |
FRAX597FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively. |
(e) FRAX597 (1 μM) for 1 h, and seeded onto Matrigel. 2F-2B cells were supplemented with exosomes (30 μg). After 24 h culture, tube formation was analysed and imaged. Scale bar = 50 μm. (representative images from n=3, *p<0.05, **p<0.01 and NS = no significant difference).
|
|
| S7807 |
FRAX486FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively. |
||
| S7989 |
FRAX1036FRAX-1036 is a potent and selective PAK inhibitor with biochemical potency (Ki) of 23.3 nM and 72.4 nM against PAK1 and PAK2. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S7093 |
IPA-3IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6). |
(e) Immunoblot analysis of p-ERM, p-Pak1 and Pak1 in Ishikawa cells treated with various doses of Pak1 inhibitor IPA-3 for 24 h. Actin serves as a loading control
|
|
| S7094 |
PF-3758309PF-03758309 is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4 with IC50 of 1.3 nM. |
(C) MEF lysates treated with 10 μM PF-3758309 and DMSO as control were loaded in a PhosTag gel. Phospho- and dephospho-proteins (PAK6 and 14-3-3γ) were visualized using anti-PAK6 or anti-pSer560 antibody and anti-14-3-3γ or anti-pSer58. Protein loading was controlled by western blot using anti-PAK6 and anti-14-3-3γ antibodies.
|
|
| S8444New |
KPT-9274KPT-9274 is an orally bioavailable small molecule that is a non-competitive dual inhibitor of PAK4 and NAMPT. It shows an IC50 of ~120 nM for NAMPT in a cell-free enzymatic assay. |
||
| S7271 |
FRAX597FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively. |
(e) FRAX597 (1 μM) for 1 h, and seeded onto Matrigel. 2F-2B cells were supplemented with exosomes (30 μg). After 24 h culture, tube formation was analysed and imaged. Scale bar = 50 μm. (representative images from n=3, *p<0.05, **p<0.01 and NS = no significant difference).
|
|
| S7807 |
FRAX486FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively. |
||
| S7989 |
FRAX1036FRAX-1036 is a potent and selective PAK inhibitor with biochemical potency (Ki) of 23.3 nM and 72.4 nM against PAK1 and PAK2. |
